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734 records identified 
through database 
searching 
4 records identified through 
bibliographies/references 
139 records removed due to 
duplication 
599 records after duplicates 
removed 
534 records removed due to 
ineligibility (e.g. review articles, 
central disorders) 
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rs10485179	 CNR1	 	 -	 Intron	 -	 -	 • No	association	with	obesity-related	or	glucose	metabolism	parameters.13	
rs35761398	 CNR2	 A>G	 188	 Exon	 Gln>Arg	 63	 • No	association	with	BMI,	HOMAir,	TC,	HDL-C	or	TG	levels.95	
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Col	Araz	et	al.	2012	15	 200	 	 Obese	
children	
BMI	 rs1049353	 Mutant	allele	associated	with	childhood	obesity	 Positive	=	1	
	









































































































































































Dinu	et	al.	2011	75	 305	 -	 Romanian,	
35-75	years		
































































































































































































































































































































































































































































































































































































































































































European	 HDL-C	 rs806371	 Mutant	allele	associated	with	lower	HDL-C	levels	 Negative	=	1	
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